A detailed history of Main Street Group, LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Main Street Group, LTD holds 42 shares of LLY stock, worth $33,418. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42
Previous 53 20.75%
Holding current value
$33,418
Previous $47,000 21.28%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $8,493 - $10,560
-11 Reduced 20.75%
42 $37,000
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $72,487 - $90,904
-100 Reduced 65.36%
53 $47,000
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $7,106 - $9,507
12 Added 8.51%
153 $119,000
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $74,051 - $87,297
141 New
141 $82.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Main Street Group, LTD Portfolio

Follow Main Street Group, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Group, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Group, LTD with notifications on news.